Strattera

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 18 USDMF, 10 CEP/COS, 7 JDMF, 15 EU WC, 18 KDMF, 17 NDC API, 26 Listed Suppliers

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

614 FDF Dossiers, 78 FDA Orange Book, 353 Europe, 66 Canada, 14 Australia, 50 South Africa, 53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 18MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 60MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Finar, 2 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 3 Lonza Capsugel, 2 Pluviaendo, 1 Qualicaps, 8 Roquette, 2 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Fillers, Diluents & Binders, 8 Empty Capsules, 7 Direct Compression, 6 Coating Systems & Additives, 6 Taste Masking, 5 Co-Processed Excipients, 4 Granulation, 4 Topical, 4 Lubricants & Glidants, 4 Film Formers & Plasticizers, 3 Chewable & Orodispersible Aids, 3 Thickeners and Stabilizers, 3 Disintegrants & Superdisintegrants, 2 Solubilizers, 2 Emulsifying Agents, 1 Surfactant & Foaming Agents, 1 Controlled & Modified Release, 1 Parenteral, 1 API Stability Enhancers

DIGITAL CONTENT

21 News #PharmaBuzz

21 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 12 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

9 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 16 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Strattera

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Strattera? Find Coloring Agents used in Strattera to address drug delivery challenges on PharmaCompass.

Strattera

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers

18 USDMF

10 CEP/COS

7 JDMF

15 EU WC

18 KDMF

17 NDC API

26 Listed Suppliers

DEVELOPMENTS

17 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

614 FDF Dossiers

78 FDA Orange Book

353 Europe

66 Canada

14 Australia

50 South Africa

53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 18MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 60MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

4 ACG Worldwide

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 BASF

1 Finar

2 Gangwal Chemicals

2 Ingredion Pharma Solutions

3 Lonza Capsugel

2 Pluviaendo

1 Qualicaps

8 Roquette

2 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Sigachi Industries

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Fillers, Diluents & Binders

8 Empty Capsules

7 Direct Compression

6 Coating Systems & Additives

6 Taste Masking

5 Co-Processed Excipients

4 Granulation

4 Topical

4 Lubricants & Glidants

4 Film Formers & Plasticizers

3 Chewable & Orodispersible Aids

3 Thickeners and Stabilizers

3 Disintegrants & Superdisintegrants

2 Solubilizers

2 Emulsifying Agents

1 Surfactant & Foaming Agents

1 Controlled & Modified Release

1 Parenteral

1 API Stability Enhancers

DIGITAL CONTENT

21 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions

12 Regulatory FDF Prices

6 Annual Reports

MARKET PLACE

9 APIs

CAPSULE;ORAL - EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 18MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 25MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 40MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 60MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 80MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons